CN113549659A - Method for preparing beta-halogenated ether and beta-halogenated alcohol by peroxidase catalysis - Google Patents

Method for preparing beta-halogenated ether and beta-halogenated alcohol by peroxidase catalysis Download PDF

Info

Publication number
CN113549659A
CN113549659A CN202110849908.XA CN202110849908A CN113549659A CN 113549659 A CN113549659 A CN 113549659A CN 202110849908 A CN202110849908 A CN 202110849908A CN 113549659 A CN113549659 A CN 113549659A
Authority
CN
China
Prior art keywords
peroxidase
derived
formula
beta
peroxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110849908.XA
Other languages
Chinese (zh)
Other versions
CN113549659B (en
Inventor
张武元
陈少航
孙周通
马延和
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin Institute of Industrial Biotechnology of CAS
Original Assignee
Tianjin Institute of Industrial Biotechnology of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Institute of Industrial Biotechnology of CAS filed Critical Tianjin Institute of Industrial Biotechnology of CAS
Priority to CN202110849908.XA priority Critical patent/CN113549659B/en
Publication of CN113549659A publication Critical patent/CN113549659A/en
Application granted granted Critical
Publication of CN113549659B publication Critical patent/CN113549659B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0065Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y111/00Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01Peroxidases (1.11.1)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention discloses a method for preparing beta-halogenated ether and beta-halogenated alcohol by peroxidase catalysis. It comprises the following steps: adding hydrogen peroxide, halogen salt and olefin shown in a formula III into a buffer solution, finally adding peroxidase, and reacting to obtain beta-halohydrin shown in a formula I; when alcohol shown as a formula IV is also added into the reaction system, beta-halogenated ether shown as a formula II is obtained; in the formula I, the formula II, the formula III and the formula IV, R1Is alkyl, phenyl, substituted phenyl, aryl or substituted aryl; r2Is hydrogen, alkyl, phenyl, substituted phenyl, aryl or substituted aryl; wherein, also includes R1And R2Linked as a cycloalkyl group; r3Is alkyl, phenyl, substituted phenyl, aryl or substituted aryl. The invention has the advantages of simple and easily obtained raw materials and reactionThe method has the advantages of mild conditions and simple and convenient operation, and the used solvent is water, so the method is more green and environment-friendly compared with the conventional organic solvent.

Description

Method for preparing beta-halogenated ether and beta-halogenated alcohol by peroxidase catalysis
Technical Field
The invention relates to a method for preparing beta-halogenated ether and beta-halogenated alcohol by peroxidase catalysis, belonging to the technical field of biology.
Background
The halogenated ether compounds are widely applied. Several general anesthetic drugs commonly used in the market today, such as sevoflurane, isoflurane, etc., contain halogenated ether building blocks. For example, sevoflurane is one of the widely used general anesthetic drugs, and has the advantages of low metabolic rate, low irritation, rapid elimination and the like. In 1981, Coon Clifford L et al used 1,1,1,3,3, 3-hexafluoro-2-propanol (HFIP) as a raw material to react with paraformaldehyde in an excess of hydrogen fluoride gas and oleum to synthesize sevoflurane. In the reaction, the hydrogen fluoride is toxic gas with pungent smell, the price is high, the environmental pollution is caused, and the fuming sulfuric acid belongs to dangerous chemicals and has strong irritation and corrosion effects on skin mucosa, tissues and the like of a human body. It can be seen that the synthesis conditions of the halogen-containing ether compounds are harsh, and the large-scale synthesis is limited due to these reasons. In 2000, Christopher Bieniarz et al developed a relatively environmentally friendly synthetic method that did not require the use of toxic reagents. And the HFIP is also taken as a raw material, aluminum trichloride is introduced to catalyze and synthesize a chloromethyl ether compound of the HFIP, and then paraformaldehyde is added into a reaction system to synthesize a target compound. Although the method is improved, a large amount of heat is released in the reaction process, a fire is easily caused, and the temperature of the system needs to be strictly controlled. The paraformaldehyde also has the danger of combustion and explosion in case of naked fire, which also limits the large-scale production and application of the method.
Halohydrins are important structural units in the fields of organic synthesis, medicine, industrial chemistry, and the like, and are also widely used for synthesizing pigments, photographic materials, and the like. The halohydrin may be further converted to an epoxide or other functional compound. The traditional method for synthesizing the halohydrin is obtained by treating olefin with halogen in aqueous solution, but by-products are generated due to high reaction activity of the halogen in the method. In addition to the above-described methods, ring opening of the epoxide with a metal halide or hydrogen halide can also produce the corresponding halohydrin compound, but the methods can also produce the corresponding dihalide and diol compound as by-products. In recent years, various optimized halohydrin synthesis methods have been reported. 20In 02, m.arjun Reddy et al, achieved high conversion yields of epoxides to β -halohydrins by ring-opening the epoxide with hydrogen halide or lithium halide in the presence of cyclodextrin. Subsequently, processes for the direct conversion of olefins to halohydrins were developed, but generally the reagents were expensive and the yields were low. N-bromosuccinimide (NBS) is one of the popular brominating agents due to the advantages of mild reaction conditions, low price and the like. The by-product succinimide can be easily recovered and converted into NBS for recycling. However, the use of NBS also has some disadvantages such as longer reaction times, less than ideal for electron deficient olefin reactions, etc. In 2005, j.s.yadav et al performed hydrohalogenation of olefins using a recyclable ionic liquid as a reaction medium and N-halosuccinimide as a halogen source, thereby improving selectivity. However, some ionic liquids are expensive, complicated to prepare, require organic solvents, and generate byproducts, and in addition, the ionic liquids are prepared for a long time, and some ionic liquids are prepared for 24 hours. The time to form bromohydrin is also longer under some conditions. In 2006, Prodeep Phukan et al optimized the synthesis of halohydrins and reported that N, N-dibromo-p-toluenesulfonamide (TsNBr) was used without a catalyst2) A method for quickly synthesizing beta-halohydrin from olefin as a brominating agent. In addition, when the halogenated ether compound produced by the present invention is subjected to β -halogen removal, various ether compounds can be formed. The ether compound is also an important chemical intermediate and has wider application.
At present, few reports of direct synthesis of halogenated ether compounds exist, and no report is related to direct conversion of olefins into beta-halogenated ether compounds by an enzyme catalysis method in a one-step method. Therefore, a new concept and method for synthesizing the compound are needed.
Disclosure of Invention
The invention aims to provide a method for preparing beta-halogenated ether and beta-halogenated alcohol by peroxidase catalysis.
The invention uses cheap and easily available olefin and alcohol with the same or similar structures such as cyclohexene, isoamylene, styrene and the like as raw materials, uses peroxide and halide salt as cosubstrates, uses water as a solvent and peroxidase as a catalyst, and synthesizes the halogenated alcohol or halogenated ether compound by a one-step method. In the invention, the beta-halohydrin can be conveniently synthesized only by omitting an alcohol donor, so that the regulation and control of a target product are realized. The invention takes the peroxidase as the catalyst, is an environment-friendly, mild in condition and simple and convenient to operate green synthesis method, and the used peroxidase has good stability, can expand the reaction and can be used for industrial production.
The invention provides a method for preparing beta-halogenated ether and beta-halogenated alcohol by peroxidase catalysis, which comprises the following steps: adding hydrogen peroxide, halogen salt and olefin shown in a formula III into a buffer solution, finally adding peroxidase, and reacting to obtain beta-halohydrin shown in a formula I;
when alcohol shown as a formula IV is also added into the reaction system, beta-halogenated ether shown as a formula II is obtained;
Figure BDA0003182055220000021
in the formula I, the formula II, the formula III and the formula IV, R1Is alkyl, phenyl, substituted phenyl, aryl or substituted aryl;
R2is hydrogen, alkyl, phenyl, substituted phenyl, aryl or substituted aryl; wherein, also includes R1And R2Linked as a cycloalkyl group;
R3is alkyl, phenyl, substituted phenyl, aryl or substituted aryl.
In the invention, R in formula I, formula II, formula III and formula IV1Specifically, the alkyl group can be an alkyl group with 5-12 carbon atoms; r2Specifically, the alkyl group has 0 to 10 carbon atoms; r3Specifically, the alkyl group may have 1 to 10 carbon atoms.
In the present invention, the olefin may be specifically selected from at least one of cyclohexene, 1-pentene and styrene.
In the present invention, the substituted phenyl, aryl or substituted aryl may be specifically a group common in the art, and the aryl may be specifically a naphthyl group.
In the invention, the structural formula of the beta-halohydrin shown in the formula I is specifically shown as follows:
Figure BDA0003182055220000031
the structural formula of the beta-halogenated ether shown in the formula II is specifically shown as follows:
Figure BDA0003182055220000032
in the above method, the peroxidase may be selected from at least one of the following (1) to (20):
(1) vanadium-dependent chloroperoxidase CiVCPO derived from Curvularia inaequalis;
(2) a haloperoxidase, LfuCPO, derived from Leptoxyphium fumago;
(3) haloperoxidase CfCPO derived from Caldariomyces fumago;
(4) vanadium-dependent bromoperoxidase CpVBPO derived from Corallina pirtillifera;
(5) vanadium-dependent chloroperoxidase AnVBPO derived from Ascophyllum nodosum;
(6) peroxidase AaeUPO derived from Agrocybe aegerita;
(7) the peroxidase cglUPO derived from Chaetomium globosum;
(8) peroxidase MroUPO derived from Marasmius rotula;
(9) peroxidase MweUPO from Marasmius wettsteinii;
(10) peroxidase CciUPO derived from Coprinopsis cinerea;
(11) peroxidase CvUPO from Collariella virescens;
(12) peroxidase mfeUPO from Myceliophtora fergusi;
(13) peroxidase MhiUPO derived from Myceliophthora hinnulea;
(14) peroxidase MthUPO derived from Myceliophthora thermophila;
(15) a peroxidase TteUPO derived from Thielavia terrestris;
(16) the peroxidase HinUPO from Humicola insolens;
(17) the peroxidase CveUPO from Coprinus verticillatus;
(18) the peroxidase CraUPO derived from Coprinellus radians;
(19) peroxidase MroUPO derived from Marasmius rotula;
(20) peroxidase PabUPO derived from Psathyrella aberdarensis.
In the above method, the peroxidase or peroxidase is in the form of whole cells, crude enzyme powder, crude enzyme solution, or pure enzyme.
In the method, the concentration of the peroxidase can be 50-2000 nM (the enzyme activity can be 0.02-04U/ml, and 1U is the enzyme amount required for converting 1 micromole of substrate in 1 minute at room temperature), and specifically can be 500nM, 50-500 nM, 500-2000 nM, 100-1000 nM or 50-1500 nM.
In the above method, the alcohol is at least one selected from methanol, ethanol, isopropanol, isoamyl alcohol, cyclohexanol, benzyl alcohol and phenethyl alcohol;
the volume of the alcohol accounts for 5-50% of the total volume of the system of the reaction; specifically, the concentration of the surfactant is 10%, 30%, 50%, 10-30%, 30-50% or 10-50%.
In the above process, the halogenated salt is at least one selected from the group consisting of potassium bromide, potassium chloride, sodium bromide, sodium chloride, sodium iodide and potassium iodide;
in the reaction system, the concentration of the halogenated salt can be 50-200 mM; specifically, the concentration may be 50mM, 75mM, 100mM, 150mM or 50 to 150 mM.
In the above method, the reaction temperature may be 15 to 60 ℃, specifically 30 ℃, 15 to 30 ℃, 30 to 60 ℃, 20 to 40 ℃ or 25 to 45 ℃;
the reaction time can be 1-24 h, specifically 9h, 1-9 h, 9-24 h, 5-15 h or 5-20 h.
In the above method, the buffer is at least one selected from citrate buffer, phosphate buffer and HEPS buffer;
the pH of the buffer solution can be 3.5-7.5, specifically 6, 3.5-6, 6-7.5 or 5-7.
In the above method, the peroxide is hydrogen peroxide or an organic peroxide;
in the reaction system, the peroxide concentration may be 50 to 200mM, specifically 100mM, 50 to 100mM, 100 to 200mM or 70 to 150mM, and specifically 10 to 30% by mass of peroxide (in a specific example, 30% by mass of hydrogen peroxide solution) is added to the system.
In the above method, the organic peroxide is specifically at least one selected from the group consisting of t-butyl peroxide, tetrahydrofuran peroxide, benzoyl peroxide, ethylene glycol dimethyl ether peroxide, methyl ethyl ketone peroxide, peroxyacetyl nitrate, triacetoneperoxide, dioxirane and its derivatives, ether peroxide, peracetic acid, and cumene hydroperoxide.
In the above process, the post-treatment of the reaction is as follows: extracting the reacted system, taking an organic phase, drying, removing the organic solvent, and finally eluting by column chromatography to obtain purified beta-halogenated ether or beta-halogenated alcohol compound;
the organic solvent adopted for extraction is ethyl acetate;
the drying is specifically carried out by adopting anhydrous sodium sulfate or anhydrous magnesium sulfate;
the column chromatography eluent is petroleum ether containing ethyl acetate with the volume percentage content of 1-3%.
The invention has the following advantages:
the method has the advantages of simple and easily obtained raw materials, mild reaction conditions and simple and convenient operation, and the used solvent is water, so the method is more environment-friendly compared with the conventional organic solvent. The hydrogen peroxide is finally converted into water in the reaction system, and the enzyme is used as a catalyst, so that no harm is caused to the environment. Compared with the mode of directly adding hypohalous acid, the mode of generating hypohalous acid in situ not only increases the reaction activity, but also reduces the pollution to the environment. Finally, compared with other oxidases, peroxidase or peroxidase has better stability, can better resist organic solvents, and is more beneficial to industrial large-scale production.
Drawings
FIG. 1 shows a general reaction scheme for preparing a beta-halogenated ether compound according to the present invention.
FIG. 2 shows a general reaction scheme for preparing a beta-halohydrin compound according to the present invention.
FIG. 3 shows the NMR spectrum of (2-bromo-1-propoxyethyl) benzene prepared according to the invention.
FIG. 4 shows the NMR carbon spectrum of (2-bromo-1-propoxyethyl) benzene prepared according to the invention.
FIG. 5 shows the NMR spectrum of (2-bromo-1-isopropoxyethyl) benzene according to the present invention.
FIG. 6 shows the NMR carbon spectrum of (2-bromo-1-isopropoxyethyl) benzene prepared according to the present invention.
FIG. 7 shows the NMR spectrum of 2- (2-bromo-1-propoxyethyl) naphthalene prepared according to the present invention.
FIG. 8 is a NMR carbon spectrum of 2- (2-bromo-1-propoxyethyl) naphthalene according to the present invention.
FIG. 9 shows NMR spectra of 1- (2-bromo-1-propoxyethyl) -2-methoxybenzene prepared according to the invention.
FIG. 10 shows the NMR carbon spectrum of 1- (2-bromo-1-propoxyethyl) -2-methoxybenzene prepared according to the invention.
FIG. 11 shows NMR spectra of (2-bromo-1-propoxyethyl) benzene prepared according to the present invention.
FIG. 12 shows the NMR carbon spectrum of (2-bromo-1-propoxyethyl) benzene prepared according to the present invention.
FIG. 13 shows NMR spectra of 1- (2-bromo-1- (tert-butoxy) ethyl) -4-methoxybenzene prepared according to the present invention.
FIG. 14 shows a NMR carbon spectrum of 1- (2-bromo-1- (tert-butoxy) ethyl) -4-methoxybenzene prepared according to the present invention.
FIG. 15 shows NMR spectra of (2-bromo-3-chloro-1-propoxypropyl) benzene prepared according to the present invention.
FIG. 16 is a NMR carbon spectrum of (2-bromo-3-chloro-1-propoxypropyl) benzene prepared according to the present invention.
FIG. 17 shows NMR spectra of 1- (2-chloro-1-ethoxyethyl) -4-methoxybenzene prepared according to the present invention.
FIG. 18 shows the NMR carbon spectrum of 1- (2-chloro-1-ethoxyethyl) -4-methoxybenzene prepared according to the invention.
Detailed Description
The experimental procedures used in the following examples are all conventional procedures unless otherwise specified.
Materials, reagents and the like used in the following examples are commercially available unless otherwise specified.
The VCPO enzyme, vanadium-dependent chloroperoxidase VCPO from Curvularia inaegulis, was prepared as follows in the following examples:
2L of the E.coli transformant was cultured to OD in LB medium supplemented with 100. mu.g/mL ampicillin at 37 ℃600nm0.6 to 0.8. The fermentation broth was then cooled to 20 ℃, protein expression was induced after addition of 0.02% L arabinose, and incubated for 72 hours. Cells were harvested by centrifugation at 8000rpm (temperature 4 ℃) for 10 minutes. The cells were resuspended and then dissolved in Tris/H pH 8.12SO4In a buffer. The cells were disrupted and centrifuged at 15000rpm for 1 hour to remove debris. After centrifugation, an equal volume of isopropanol was added to the supernatant. After centrifugation (15000rpm for 30 minutes), the clear supernatant was applied to a DEAE Sephacel column. With 2 volumes of Tris/H2SO4And 2 volumes of NaCl Tris/H2SO4The column was washed (pH 8.1) and then the enzyme was eluted with NaCl in Tris/HCl. Finally, the pure apoenzyme was purified in Tris H2SO4(pH 8.1) 100. mu.M orthovanadate was dialyzed to obtain the holoenzyme, VCPO enzyme.
The preparation of the UPO enzyme in the following examples is as follows:
the Pichia pastoris cell culture containing rAaeUPO was clarified by centrifugation at 8000rpm for 2 hours at 4 ℃. The supernatant was filtered through a 20 μm filter and maintained at-80 ℃. raaeaupo activity was determined by using ABTS assay in NaPi buffer at pH 5.0;
protein purification: the supernatant was concentrated and dialyzed against 100mM sodium phosphate, pH 7. AaeUPO was purified in one step using NGC chromatography system (Biorad). The separation was performed on a Q Sepharose FF 30-mL column at a flow rate of 5 mL/min. After 90mL, the retained protein was eluted with a 0-50% NaCl gradient in 450mL, followed by a 50-100% gradient in 50mL and a 100% NaCl peroxidase activity in 75mL followed by H2O2ABTS in the presence was oxidized, the appropriate fractions were combined, concentrated and dialyzed against 100mM sodium phosphate buffer (pH 7). Purification of rAaeUPO was confirmed by Sodium Dodecyl Sulfate (SDS) -PAGE staining with Coomassie Brilliant blue R-250(Sigma) in 12% gel.
Example 1 preparation of the compound 1-bromo-2-ethoxycyclohexane:
Figure BDA0003182055220000061
to a 100mL reaction flask, 31.5mL of a phosphate buffer solution (sodium dihydrogenphosphate 100mM) having a pH of 6 was added, anhydrous ethanol (13.5mL) was added to the buffer solution, followed by sequentially adding 0.93mL of a 30% by mass hydrogen peroxide solution (concentration of 5.38mol/L, concentration of 100mM in the reaction system), 0.59g of potassium bromide and 0.820g of cyclohexene, and finally 150 μ L of VCPO enzyme (starting enzyme concentration of 13.5mg/mL, enzyme concentration of 500nM in the reaction system). After about 3 hours of the reaction, 0.59g of potassium bromide, 0.93mL of hydrogen peroxide (concentration: 5.38mol/L, concentration: 100mM in the reaction system) and 0.820g of cyclohexene were added thereto, and they were added three times in total. Added in separate batches to ensure maximum catalytic activity of the enzyme.
And (3) stirring the reaction system at 30 ℃ to react for about 9 hours, adding 100mL of ethyl acetate to extract after the reaction is finished, extracting twice, combining organic phases, and distilling the organic phases at 30-40 ℃ under reduced pressure to remove the organic solvent. And finally, performing column chromatography to obtain the target compound 1-bromo-2-ethoxycyclohexane (yield 42%, purity 98%), wherein the eluent is an ethyl acetate-petroleum ether mixed solution, and the volume percentage of ethyl acetate is 1-3%.
Example 2 preparation of the compound (2-bromo-1-propoxyethyl) benzene:
Figure BDA0003182055220000071
into a 100mL reaction flask, 31.5mL of a phosphate buffer solution (same pH as above 6), 13.5mL of absolute ethanol was added to dissolve in the buffer solution, and then 0.93mL of a 30% by mass hydrogen peroxide solution (concentration 5.38mol/L, concentration 100mM in the reaction system), 0.59g of potassium bromide and 0.16g of styrene were sequentially added, and finally 150 μ L of VCPO enzyme (same concentration as above 13.5mg/mL, concentration 500nM in the reaction system) was added. After about 3 hours of reaction, 0.59g of potassium bromide, 0.93mL of hydrogen peroxide (5.38 mol/L in concentration) and 0.16g of styrene were added thereto three times.
And (3) stirring the reaction system in a water bath kettle at 30 ℃ with magnetons, reacting for 9 hours, finishing the reaction, adding 100mL of ethyl acetate for extraction twice, combining organic phases, and distilling the organic phases at 30-40 ℃ under reduced pressure to remove the organic solvent. And finally, carrying out column chromatography to obtain a target compound (2-bromo-1-propoxyethyl) benzene (the yield is 48%, the purity is 99%), wherein an eluent is an ethyl acetate-petroleum ether mixed solution, and the volume percentage content of ethyl acetate is 1-3%.
As can be seen from FIGS. 3 and 4, the structure is correct.
Example 3 preparation of the compound 1-bromopentane-2-ol:
Figure BDA0003182055220000072
to a 100mL reaction flask, 31.5mL of a phosphate buffer solution (same pH as above 6) was added, followed by 0.93mL of a 30% by mass hydrogen peroxide solution (concentration 5.38mol/L, concentration 100mM in the reaction system), 0.59g of potassium bromide and 0.11g of 1-pentene, and finally 150 μ L of VCPO enzyme (same concentration as above 13.5mg/mL, concentration 500nM in the reaction system) were added. After about 3 hours of reaction, 0.59g of potassium bromide, 0.93mL of hydrogen peroxide (5.38M) and 0.105g of 1-pentene were added three times in total.
And (3) putting the reaction system in a water bath kettle at 30 ℃, carrying out magneton stirring reaction for 9 hours, finishing the reaction, adding 100mL of ethyl acetate for extraction twice, combining organic phases, and carrying out reduced pressure distillation on the organic phases at 30-40 ℃ to remove the organic solvent. And finally, carrying out column chromatography to obtain a target compound 1-bromopentane-2-alcohol (the yield is 82 percent, the purity is 98 percent), wherein an eluent is an ethyl acetate-petroleum ether mixed solution, and the volume percentage content of ethyl acetate is 1-3 percent.
Example 4 preparation of the compound (2-bromo-1-isopropoxyethyl) benzene:
Figure BDA0003182055220000081
to a 100mL reaction flask, 31.5mL of a citrate buffer solution (pH 5, citric acid 100mM), 13.5mL of isopropanol in the buffer solution, 0.93mL of a 30% hydrogen peroxide solution (concentration 5.38mol/L, concentration 100mM in the reaction system), 0.59g of potassium bromide and 0.16g of styrene were added in this order, and finally 150. mu.L of VCPO enzyme (13.5 mg/mL as in the above enzyme concentration, enzyme concentration 500nM in the reaction system) was added. After about 3 hours of reaction, 0.59g of potassium bromide, 0.93mL of hydrogen peroxide (5.38M) and 0.16g of styrene were added thereto three times in total.
And (3) putting the reaction system in a water bath kettle at 30 ℃, carrying out magneton stirring reaction for 9 hours, finishing the reaction, adding 100mL of ethyl acetate for extraction twice, combining organic phases, and carrying out reduced pressure distillation on the organic phases at 30-40 ℃ to remove the organic solvent. And finally, performing column chromatography to obtain a target compound (2-bromo-1-isopropoxyethyl) benzene (yield is 53%, purity is 98%), wherein an eluent is an ethyl acetate-petroleum ether mixed solution, and the volume percentage of ethyl acetate is 1-3%.
As can be seen from FIGS. 6 and 5, the structure is correct.
Example 5 preparation of the compound 2- (2-bromo-1-propoxyethyl) naphthalene:
Figure BDA0003182055220000082
to a 100mL reaction flask, 31.5mL of a citrate buffer solution (pH 5, citric acid 100mM), 13.5mL of propanol in the buffer solution, 0.93mL of a 30% by mass hydrogen peroxide solution (concentration 5.38mol/L, concentration 100mM in the reaction system), 0.59g of potassium bromide and 0.23g of 2-vinylnaphthalene were sequentially added, and finally 150. mu.L of VCPO enzyme (13.5 mg/mL as in the above enzyme concentration, enzyme concentration 500nM in the reaction system) was added. After about 3 hours of reaction, 0.59g of potassium bromide, 0.93mL of hydrogen peroxide (5.38M) and 0.23g of 2-vinylnaphthalene were added three times in total.
And (3) putting the reaction system in a water bath kettle at 30 ℃, carrying out magneton stirring reaction for 9 hours, finishing the reaction, adding 100mL of ethyl acetate for extraction twice, combining organic phases, and carrying out reduced pressure distillation on the organic phases at 30-40 ℃ to remove the organic solvent. And finally, performing column chromatography to obtain a target compound 2- (2-bromo-1-propoxyethyl) naphthalene (the yield is 49%, the purity is 99%), wherein an eluent is an ethyl acetate-petroleum ether mixed solution, and the volume percentage content of ethyl acetate is 1-3%.
As can be seen from fig. 7 and 8, the structure is correct.
Example 6 preparation of the compound 1- (2-bromo-1-propoxyethyl) -2-methoxybenzene:
Figure BDA0003182055220000091
to a 100mL reaction flask, 31.5mL of a phosphate buffer solution (pH 6, 100mM sodium dihydrogenphosphate), 13.5mL of propanol in the buffer solution, 0.93mL of a 30% by mass hydrogen peroxide solution (concentration 5.38mol/L, concentration 100mM in the reaction system), 0.59g of potassium bromide and 0.20g of 2-methoxystyrene were added in this order, and finally 1mL of UPO enzyme (the concentration of the proenzyme was the same as 2mg/mL, and the concentration of the enzyme in the reaction system was 500nM) was added. After about 3 hours of reaction, 0.59g of potassium bromide, 0.93mL of hydrogen peroxide (5.38M) and 0.20g of 2-methoxystyrene were added thereto three times in total.
And (3) putting the reaction system in a water bath kettle at 30 ℃, carrying out magneton stirring reaction for 9 hours, finishing the reaction, adding 100mL of ethyl acetate for extraction twice, combining organic phases, and carrying out reduced pressure distillation on the organic phases at 30-40 ℃ to remove the organic solvent. And finally, performing column chromatography to obtain a target compound 1- (2-bromo-1-propoxyethyl) -2-methoxybenzene (the yield is 56%, the purity is 98%), wherein an eluent is an ethyl acetate-petroleum ether mixed solution, and the volume percentage of ethyl acetate is 1-3%.
As can be seen from fig. 9 and 10, the structure is correct.
Example 7 preparation of the compound (2-bromo-1-propoxyethyl) benzene:
Figure BDA0003182055220000092
to a 100mL reaction flask, 31.5mL of a citrate buffer solution (pH 5, citric acid 100mM), 13.5mL of propanol in the buffer solution, 0.93mL of a 30% by mass hydrogen peroxide solution (concentration 5.38mol/L, concentration 100mM in the reaction system), 0.59g of potassium bromide and 0.18g of trans-. beta. -methylstyrene were added in this order, and finally 1mL of UPO enzyme (2 mg/mL as in the above enzyme concentration, enzyme concentration 500nM in the reaction system) was added. After about 3 hours of reaction, 0.59g of potassium bromide, 0.93mL of hydrogen peroxide (5.38M) and 0.18g of trans-beta-methylstyrene were added three times in total.
And (3) putting the reaction system in a water bath kettle at 30 ℃, carrying out magneton stirring reaction for 9 hours, finishing the reaction, adding 100mL of ethyl acetate for extraction twice, combining organic phases, and carrying out reduced pressure distillation on the organic phases at 30-40 ℃ to remove the organic solvent. And finally, carrying out column chromatography to obtain a target compound (2-bromo-1-propoxyethyl) benzene (the yield is 43 percent, the purity is 99 percent), wherein an eluent is an ethyl acetate-petroleum ether mixed solution, and the volume percentage content of ethyl acetate is 1-3 percent.
As can be seen from fig. 11 and 12, the structure is correct.
Example 8 preparation of the compound 1- (2-bromo-1- (tert-butoxy) ethyl) -4-methoxybenzene:
Figure BDA0003182055220000101
to a 100mL reaction flask, 31.5mL of a phosphate buffer solution (pH 6, 100mM sodium dihydrogenphosphate), 13.5mL of t-butanol in the buffer solution, 0.93mL of a 30% by mass hydrogen peroxide solution (concentration 5.38mol/L, concentration 100mM in the reaction system), 0.59g of potassium bromide and 0.20g of p-methoxystyrene were added in this order, and finally 150. mu.L of VCPO enzyme (13.5 mg/mL as in the above example, and enzyme concentration 500nM in the reaction system) was added. After about 3 hours of reaction, 0.59g of potassium bromide, 0.93mL of hydrogen peroxide (5.38M) and 0.20g of p-methoxystyrene were added thereto three times in total.
And (3) putting the reaction system in a water bath kettle at 30 ℃, carrying out magneton stirring reaction for 9 hours, finishing the reaction, adding 100mL of ethyl acetate for extraction twice, combining organic phases, and carrying out reduced pressure distillation on the organic phases at 30-40 ℃ to remove the organic solvent. And finally, performing column chromatography to obtain the target compound 1- (2-bromo-1- (tert-butoxy) ethyl) -4-methoxybenzene (yield is 49%, purity is 99%), wherein an eluent is an ethyl acetate-petroleum ether mixed solution, and the volume percentage of ethyl acetate is 1-3%.
As can be seen from fig. 13 and 14, the structure is correct.
Example 9 preparation of the compound (2-bromo-3-chloro-1-propoxypropyl) benzene:
Figure BDA0003182055220000102
to a 100mL reaction flask, 31.5mL of a phosphate buffer solution (pH 6, 100mM sodium dihydrogenphosphate), 13.5mL of propanol in the buffer solution, 0.93mL of a 30% by mass hydrogen peroxide solution (concentration 5.38mol/L, concentration 100mM in the reaction system), 0.59g of potassium bromide and 0.23g of cinnamyl chloride were added in this order, and finally 150. mu.L of VCPO enzyme (13.5 mg/mL as in the above example, concentration 500nM of enzyme in the reaction system) was added. After about 3 hours of reaction, 0.59g of potassium bromide, 0.93mL of hydrogen peroxide (5.38M) and 0.23g of cinnamyl chloride were added three times in total.
And (3) putting the reaction system in a water bath kettle at 30 ℃, carrying out magneton stirring reaction for 9 hours, finishing the reaction, adding 100mL of ethyl acetate for extraction twice, combining organic phases, and carrying out reduced pressure distillation on the organic phases at 30-40 ℃ to remove the organic solvent. And finally, performing column chromatography to obtain a target compound (2-bromo-3-chloro-1-propoxypropyl) benzene (the yield is 47 percent and the purity is 99 percent), wherein an eluent is an ethyl acetate-petroleum ether mixed solution, and the volume percentage content of ethyl acetate is 1-3 percent.
As can be seen from fig. 15 and 16, the structure is correct.
Example 10 preparation of the compound 1- (2-chloro-1-ethoxyethyl) -4-methoxybenzene:
Figure BDA0003182055220000111
to a 100mL reaction flask, 31.5mL of a phosphate buffer solution (pH 6, 100mM sodium dihydrogenphosphate), 13.5mL of ethanol in the buffer solution, 0.93mL of a 30% hydrogen peroxide solution (concentration 5.38mol/L, concentration 100mM in the reaction system), 0.59g of potassium bromide and 0.20g of p-methoxystyrene in this order, and finally 150. mu.L of VCPO enzyme (13.5 mg/mL as in the above example, and enzyme concentration 500nM in the reaction system) were added. After about 3 hours of reaction, 0.59g of potassium bromide, 0.93mL of hydrogen peroxide (5.38M) and 0.20g of p-methoxystyrene were added thereto three times in total.
And (3) putting the reaction system in a water bath kettle at 30 ℃, carrying out magneton stirring reaction for 9 hours, finishing the reaction, adding 100mL of ethyl acetate for extraction twice, combining organic phases, and carrying out reduced pressure distillation on the organic phases at 30-40 ℃ to remove the organic solvent. And finally, performing column chromatography to obtain a target compound 1- (2-chloro-1-ethoxyethyl) -4-methoxybenzene (the yield is 45%, the purity is 99%), wherein an eluent is an ethyl acetate-petroleum ether mixed solution, and the volume percentage content of ethyl acetate is 1-3%.
As can be seen from fig. 17 and 18, the structure is correct.
Comparative example (c),
The chemical method comprises the following steps:
the chemical method is characterized in that hypochlorous acid is used for replacing hydrogen peroxide, potassium bromide and VCPO, and the reaction equation is as follows:
Figure BDA0003182055220000112
0.27mL of propanol was added to 0.63mL of water, followed by 16.85. mu.L of styrene stock solution (0.1854g of styrene in 1mL of acetonitrile), 80. mu.L of sodium hypochlorite solution (0.5mol/L) and reaction for 5h in a shaker 800 r.
And (3) post-treatment: 200 μ L of the reaction mixture was extracted with 0.4mL of ethyl acetate containing an internal dodecane standard, and the organic layer was collected, dried over anhydrous sodium sulfate, and then monitored by gas chromatography.
According to the results of gas chromatography, only trace product formation was observed in the comparative example, and the concentration of the compound which was isolated as a pure product was not reached, and the compound could not be isolated. The sodium hypochlorite solution used in the chemical method preparation of the compounds is easy to decompose, the reaction failure rate is high, and the hypohalous acid radical is generated in situ in the enzymatic method preparation, so that the reaction is easier to carry out.
From the experimental results, the sodium hypochlorite solution used in the chemical method for preparing the compounds in the comparative example is easy to decompose, the failure rate of the reaction is high, and the hypohalous acid radical is generated in situ in the enzymatic method for preparing the compounds, so that the reaction is easier to carry out.
The above embodiments are merely preferred embodiments of the present invention, and it should be understood by those skilled in the art that the embodiments are not exemplary, and do not limit the scope of the present invention. Any person skilled in the art should also be able to make equivalent substitutions or changes in the details or forms thereof within the technical scope of the invention as set forth, according to the technical solution of the invention and the inventive concept thereof, and within the scope of the invention.

Claims (10)

1. A process for the peroxidase-catalyzed production of a β -haloether and a β -halohydrin, comprising the steps of: adding hydrogen peroxide, halogen salt and olefin shown in a formula III into a buffer solution, finally adding peroxidase, mixing and reacting to obtain beta-halohydrin shown in a formula I;
when alcohol shown as a formula IV is also added into the reaction system, beta-halogenated ether shown as a formula II is obtained;
Figure FDA0003182055210000011
in the formula I, the formula II, the formula III and the formula IV, R1Is alkyl, phenyl, substituted phenyl, aryl or substituted aryl;
R2is hydrogen, alkyl, phenyl, substituted phenyl, aryl or substituted aryl; wherein, also includes R1And R2Linked as a cycloalkyl group;
R3is alkyl, phenyl, substituted phenyl, aryl or substituted aryl.
2. The method of claim 1, wherein: the peroxidase is selected from at least one of the following (1) to (20):
(1) vanadium-dependent chloroperoxidase CiVCPO derived from Curvularia inaequalis;
(2) a haloperoxidase, LfuCPO, derived from Leptoxyphium fumago;
(3) haloperoxidase CfCPO derived from Caldariomyces fumago;
(4) vanadium-dependent bromoperoxidase CpVBPO derived from Corallina pirtillifera;
(5) vanadium-dependent chloroperoxidase AnVBPO derived from Ascophyllum nodosum;
(6) peroxidase AaeUPO derived from Agrocybe aegerita;
(7) the peroxidase cglUPO derived from Chaetomium globosum;
(8) peroxidase MroUPO derived from Marasmius rotula;
(9) peroxidase MweUPO from Marasmius wettsteinii;
(10) peroxidase CciUPO derived from Coprinopsis cinerea;
(11) peroxidase CvUPO from Collariella virescens;
(12) peroxidase mfeUPO from Myceliophtora fergusi;
(13) peroxidase MhiUPO derived from Myceliophthora hinnulea;
(14) peroxidase MthUPO derived from Myceliophthora thermophila;
(15) a peroxidase TteUPO derived from Thielavia terrestris;
(16) the peroxidase HinUPO from Humicola insolens;
(17) the peroxidase CveUPO from Coprinus verticillatus;
(18) the peroxidase CraUPO derived from Coprinellus radians;
(19) peroxidase MroUPO derived from Marasmius rotula;
(20) peroxidase PabUPO derived from Psathyrella aberdarensis.
3. The method according to claim 1 or 2, characterized in that: the peroxidase plays a catalytic role in the form of whole cells, crude enzyme powder, crude enzyme liquid or pure enzyme.
4. The method according to claim 1 or 2, characterized in that: the concentration of the peroxidase is 50-2000 nM.
5. The method according to claim 1 or 2, characterized in that: the alcohol is selected from at least one of methanol, ethanol, isopropanol, isoamyl alcohol, cyclohexanol, benzyl alcohol and phenethyl alcohol;
the volume of the alcohol accounts for 5-50% of the total volume of the reaction system.
6. The method according to any one of claims 1-3, wherein: the halogenated salt is at least one selected from potassium bromide, potassium chloride, sodium bromide, sodium chloride, sodium iodide and potassium iodide;
in the reaction system, the concentration of the halogenated salt is 50-200 mM.
7. The method according to any one of claims 1-4, wherein: the reaction temperature is 15-60 ℃;
the reaction time is 1-24 hours.
8. The method according to any one of claims 1-5, wherein: the buffer solution is selected from at least one of citrate buffer solution, phosphate buffer solution and HEPS buffer solution;
the pH value of the buffer solution is 3.5-7.5.
9. The method according to any one of claims 1-6, wherein: the peroxide comprises hydrogen peroxide or an organic peroxide;
in the reaction system, the concentration of the peroxide is 50-200 mM.
The organic peroxide is at least one selected from tert-butyl peroxide, tetrahydrofuran peroxide, benzoyl peroxide, ethylene glycol dimethyl ether peroxide, methyl ethyl ketone peroxide, peroxyacetyl nitrate, tripropoxide, dioxirane and derivatives thereof, ether peroxide, peroxyacetic acid and cumene hydroperoxide.
10. The method according to any one of claims 1-9, wherein: the post-treatment of the reaction was as follows: extracting the reacted system, taking an organic phase, drying, removing the organic solvent, and finally eluting by column chromatography to obtain purified beta-halogenated ether and beta-halogenated alcohol compounds;
the organic solvent adopted for extraction is ethyl acetate;
the drying is specifically carried out by adopting anhydrous sodium sulfate or anhydrous magnesium sulfate;
the column chromatography eluent is petroleum ether containing ethyl acetate with the volume percentage content of 1-3%.
CN202110849908.XA 2021-07-27 2021-07-27 Method for preparing beta-halogenated ether and beta-halogenated alcohol by peroxidase catalysis Active CN113549659B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110849908.XA CN113549659B (en) 2021-07-27 2021-07-27 Method for preparing beta-halogenated ether and beta-halogenated alcohol by peroxidase catalysis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110849908.XA CN113549659B (en) 2021-07-27 2021-07-27 Method for preparing beta-halogenated ether and beta-halogenated alcohol by peroxidase catalysis

Publications (2)

Publication Number Publication Date
CN113549659A true CN113549659A (en) 2021-10-26
CN113549659B CN113549659B (en) 2022-07-26

Family

ID=78132972

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110849908.XA Active CN113549659B (en) 2021-07-27 2021-07-27 Method for preparing beta-halogenated ether and beta-halogenated alcohol by peroxidase catalysis

Country Status (1)

Country Link
CN (1) CN113549659B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114045314A (en) * 2022-01-04 2022-02-15 中国科学院天津工业生物技术研究所 Method for preparing 2-hydroxytetrahydrofuran, 1, 4-butyrolactone and gamma-sodium hydroxybutyrate through enzyme catalysis
CN114480472A (en) * 2022-01-24 2022-05-13 河北工业大学 Process for producing fusion enzyme and fusion enzyme
CN114717271A (en) * 2021-12-22 2022-07-08 中国科学院天津工业生物技术研究所 Method for synthesizing calcitriol by hydroxylation of oxidase
CN115724911A (en) * 2022-06-07 2023-03-03 清枫链食苏打饮品(吉林)有限公司 Donkey-hide gelatin peptide and application thereof in preparing health-care products related to qi tonifying, blood nourishing or miscarriage prevention

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11341996A (en) * 1998-05-30 1999-12-14 Dainichiseika Color & Chem Mfg Co Ltd Determination of peroxidase activity
CN102676597A (en) * 2011-03-16 2012-09-19 苏州国镝医药科技有限公司 Method for chirally synthesizing liptor intermediate ATS-5 with bioenzyme

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11341996A (en) * 1998-05-30 1999-12-14 Dainichiseika Color & Chem Mfg Co Ltd Determination of peroxidase activity
CN102676597A (en) * 2011-03-16 2012-09-19 苏州国镝医药科技有限公司 Method for chirally synthesizing liptor intermediate ATS-5 with bioenzyme

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JAYME N CARTER-FRANKLIN等: "Vanadium bromoperoxidase-catalyzed biosynthesis of halogenated marine natural products", 《J. AM. CHEM. SOC.》 *
JIA JIA DONG等: "Halofunctionalization of alkenes by vanadium chloroperoxidase from Curvularia inaequalis", 《CHEM. COMMUN.》 *
曾志刚等: "卤过氧化物酶在绿色卤化反应中的研究进展", 《有机化学》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114717271A (en) * 2021-12-22 2022-07-08 中国科学院天津工业生物技术研究所 Method for synthesizing calcitriol by hydroxylation of oxidase
CN114045314A (en) * 2022-01-04 2022-02-15 中国科学院天津工业生物技术研究所 Method for preparing 2-hydroxytetrahydrofuran, 1, 4-butyrolactone and gamma-sodium hydroxybutyrate through enzyme catalysis
CN114045314B (en) * 2022-01-04 2022-04-12 中国科学院天津工业生物技术研究所 Method for preparing 2-hydroxytetrahydrofuran, 1, 4-butyrolactone and gamma-sodium hydroxybutyrate through enzyme catalysis
CN114480472A (en) * 2022-01-24 2022-05-13 河北工业大学 Process for producing fusion enzyme and fusion enzyme
CN115724911A (en) * 2022-06-07 2023-03-03 清枫链食苏打饮品(吉林)有限公司 Donkey-hide gelatin peptide and application thereof in preparing health-care products related to qi tonifying, blood nourishing or miscarriage prevention

Also Published As

Publication number Publication date
CN113549659B (en) 2022-07-26

Similar Documents

Publication Publication Date Title
CN113549659B (en) Method for preparing beta-halogenated ether and beta-halogenated alcohol by peroxidase catalysis
Chen Recent development of biomimetic halogenation inspired by vanadium dependent haloperoxidase
US8716503B2 (en) Process for preparing divinylarene dioxides
CA3058264A1 (en) Treatment of quarry liquid effluent
JP5894144B2 (en) Production process of divinylarene dioxide
CN103212437A (en) Method for preparing titanium-based catalyst and synthesizing epoxypropane and dicumyl peroxide
Neuhaus et al. Oxidative dehydrogenative couplings of alkenyl phenols
CN113666915A (en) Preparation method of posaconazole intermediate
Amantini et al. Nucleophilic ring opening of 1, 2-epoxides in aqueous medium
KR20140041434A (en) Process for the preparation of alditol acetals
CN109206396B (en) Preparation method of 2-C-methyl-4,5-O- (1-methylvinyl) -D-arabinonic acid ethyl ester
US5723636A (en) Methyltrioxorhenium-urea hydrogen peroxide epoxidation of olefins
CN105441503B (en) A kind of method that enzymatic reaction prepares 2,3- epoxypinane
US4053525A (en) Process for production of glycerine
CN112028799A (en) Preparation method of 1, 4-dithiothreitol
CN112159372A (en) Preparation method of bicalutamide
CN111253343B (en) Method for preparing styrene oxide by using metal-free catalyst
CN105461660A (en) Preparation method for 1,2-epoxycyclopentane
EP0094726A1 (en) Process for the transformation of an aldehyde or a ketone into the corresponding epoxide, in particular of furfural into furfuryl oxiranes
CN114292163B (en) Method for preparing isopulegol from citronellal
Loh et al. A versatile and practical synthesis of α-trifluoromethylated alcohols from trifluoroacetaldehyde ethyl hemiacetal in water
CN110156723B (en) Synthesis method of 1, 2-epoxy compound
NL2018481B1 (en) Oxidation of alkenes
CN108689894B (en) Synthesis method of green high-conversion-number sulfoxide compound
KR19980080497A (en) Improved Method of Making Trifluoromethyl Oxirane

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant